Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CVS Health (CVS)

CVS Health Adds John Gallina, Former Elevance CFO, to Board and Audit Committee

Neutral Impact 2 of 5 leadership Written later

CVS Health's Board elected John E. Gallina, former Elevance Health CFO, as a director effective March 19, 2026, and appointed him to the Audit Committee. The Board determined he is independent, and the filing describes him as an audit committee financial expert.

Key points

  • Board elected John E. Gallina, age 66, effective March 19, 2026; Board action taken March 18, 2026
  • Gallina served as Elevance Health CFO from June 2016 through November 1, 2023, and retired in May 2024
  • Appointed to the Audit Committee and designated an audit committee financial expert under SEC rules
  • Compensation as a non-employee director will be consistent with other directors, prorated for his start date

The filing

CompanyCVS Health (CVS)
Form8-K, current report
Filed with the SECMar 19, 2026, 4:08 PM ET
Accession number0000064803-26-000017

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 19, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.